Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Hormonal therapies are safe and effective for treating adult women's acne.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.